Biocryst Pharmaceuticals buy Bank of America Co.
Start price
01.07.25
/
50%
€7.65
Target price
01.07.26
€12.73
Performance (%)
-15.63%
Price
12.12.25
€6.45
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.63%. This prediction currently runs until 01.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -1.073% | -1.073% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat